Skip to content

Nonpharmacologic Reduction of Periprocedural Distress and Drug Use

Nonpharmacologic Reduction of Periprocedural Pain, Anxiety, and Prescription Drug Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03328208
Enrollment
72
Registered
2017-11-01
Start date
2017-11-22
Completion date
2018-12-31
Last updated
2021-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Anxiety, Dental Pain, Drug Use, Opioid Use

Keywords

Nonpharmacologic analgesia, Medical app, Relaxation

Brief summary

Objectives of this Phase I pilot trial are to provide data towards assessing and facilitating feasibility of a larger scale Phase II trial in which the effects of a calmative Comfort Talk® app can be unequivocally evaluated. Towards this goal we will pursue following outcome parameters for Phase I: Feasibility/acceptability assessment: Primary outcome parameter: • ability to obtain complete on-site data sets from at least 90% of patients enrolled (with at least 40% from patients in the app group and at least 40% from patients in the control group). Secondary outcome parameters: * ability to enroll 60 patients by day 150 after initiation of recruitment in the clinic (=day 1) * obtain 38 packages of filled out diary cards (at least 16 from patients in the app group and at least 16 from patients in the control group) * 90% of patients in app group listen to app ≥5 min Phase II preparation primary outcome parameter • anxiety at the end of the waiting room time Secondary outcome parameters * pain the end of the waiting room time * anxiety during treatment * pain during treatment * anxiety during 1 week after treatment * pain during 1 week after treatment * use of units of sedatives and analgesics during 1 week after treatment (assessed by prescription at end of the visit) * patient satisfaction

Detailed description

The design is a single-blind, placebo controlled clinical trial to test the feasibility of the trial design assessing the ability of a Comfort Talk® app to nonpharmacologically reduce anxiety, pain, and periprocedural drug use in individuals 18 years of age and older undergoing outpatient treatment in the Craniofacial Pain Center of the Tufts School of Dental Medicine. The trial is a single-site pilot trial to assist in sample size estimation in a pivotal trial to test the hypothesis that listening to a Comfort Talk® app with calmative content reduces pain, anxiety, and post-procedural medication use. Eligible patients at the Craniofacial Pain Center at the Tufts School of Dental Medicine (TUSDM) will be randomized to listen to a tablet containing a calmative Comfort Talk® app or app with white noise on an intent-to-treat basis. Their anxiety and pain measures will be recorded on validated 0-10 scales and before listening, at the end of the waiting room period, and every 10 minutes while on the dental chair. All patients will be given a packet with diary cards to record their levels of anxiety, pain, and drug use daily for 7 days after their visit and asked to send those back. Subjects will be mailed a $25 check upon returning their diaries. Patients randomized to the Comfort Talk® app will receive a download coupon for the app before leaving TUSDM, those randomized to the control condition (white noise) will receive a download coupon after they send in their diary cards. Interventions and Duration Approximately 1 hour and 15 minutes (Up to 30 minutes more than the scheduled standard of care visit, which will typically last up to 45 minutes): Patient will be asked to come in ½ hour early before an already scheduled appointment. They will be taken to a private area, report their demographics, and if eligible consented and fill out a NIDA Quick Screen. The participant will then be verbally asked to indicate his/her pain and anxiety levels on validated 0-10 scales. The research assistant will then hand the participant a tablet containing, depending on the group attribution, either the app (App Group) or white noise (Control Group) and will be shown how to operate the tablet. Participant will then return to the clinic waiting area with the tablet and wait for their regularly scheduled appointment. The patient will be at liberty to when and for how long to listen. At the end of the waiting room period the participant will be queried again for their levels of pain and anxiety. After the participant enters the treatment room, he or she will be able to continue to listen to the app or white noise on the tablet. The research assistant will ask the participant every 10 min to indicate their pain and anxiety levels. The research assistant will note the duration of chair time, the amount of lidocaine given, if any or which other medications were given during the appointment, and whether the dental practitioner prescribed opioid, prescription or non-prescription drugs at the end of the visit. Before leaving home, the participant will be asked to fill out a satisfaction survey based on a modified Press Ganey Template. The participant will then receive a diary card on which to note pain, average and maximal pain as well its location, use of non-prescription, prescription, and opiate drugs, use of the app, and be provided pre-stamped envelopes. Patients will be asked to complete the diary daily before bedtime for 7 days.

Interventions

Test app

OTHERWhite Noise app

White Noise app built to mimic appearance of Comfort Talk® test app

Sponsors

Tufts University
CollaboratorOTHER
Hypnalgesics, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Masking description

The four tablets used in the study will be labeled A,B,C,D and will be preloaded with the app or white noise by the Hypnalgesics, LLC in randomized sequence. Personnel at TUSDM will not be aware which tablet presents test or control content. The opening screen and option screen of the white noise control app will use the same color scheme and lay-out as the one of the test Comfort Talk app. The statistical team will receive the encoded data entries and will not be informed about the content of the tablets until all analyses are completed. Since they also will not have direct contact with the study patients they are also not at risk of becoming unblinded during app use by the patients. At the end of their visit, patients will receive a sealed envelope which according to their number will either contain a download coupon for the app for home use or a thank you note. To maintain blinding, all patients who send their diaries back will receive a download coupon.

Intervention model description

This is a single-blind placebo-controlled trial comparing a Comfort Talk® calmative app (App Group) with a white noise app (Control Group).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled to undergo a dental procedure at the Craniofacial Pain Center * Able to hear, write and read in English, as the ComfortTalk® scripts, study scales and take-home diary are in English * Able to operate a standard smart tablet or smart phone and have access to a smart tablet, smart phone at home, or computer-based app download * Willing and able to give informed consent

Exclusion criteria

* Known acute psychiatric disorder, such as multiple personalities which will be assessed on the medical history form * Not meeting inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Complete On-Site Data SetsDuration of outpatient clinic visit (up to 2 hrs)Feasibility defined as the ability to obtain complete on-site data sets from at least 90% of participants enrolled (with at least 40% from patients in the app group and at least 40% from patients in the control group).

Secondary

MeasureTime frameDescription
Number of Days to Enroll 60 ParticipantsUp to 150 daysFeasibility measure defined as the ability to enroll 60 participants by day 150 after initiation of recruitment in the clinic (=day 1). Outcome measure are numbers of office days from the start of enrollment
Number of Participants Returning Diary Card PackagesUp to 6 monthsFollow-up feasibility defined as obtaining 38 packages of filled out diary cards (at least 16 from patients in the app group and at least 16 from patients in the control group)

Other

MeasureTime frameDescription
Anxiety During Dental TreatmentUp to 120 minTime course of anxiety as measured by self-report on a 0-10 scale with 0=no anxiety at all and 10=worst anxiety possible (average over 10 minute intervals)
Average Maximal Anxiety During 1 Week After Dental Treatment7 daysAverage maximal daily anxiety as measured daily by self-report on a 0-10 scale with 0=no anxiety at all and 10=worst anxiety possible
Anxiety at the End of the Waiting Room Time (Change as Compared to Beginning of the Waiting Room Time)Up to 60 minAnxiety as measured by self-report on a 0-10 scale with 0=no anxiety at all and 10=worst anxiety possible; change from the beginning to the end of the waiting room time
Number of Participants Receiving New Prescriptions for Drugs7 daysParticipants receiving new prescriptions for drugs at the end of their visit for the subsequent week (alone or in combination opioids, non-opioid analgesics, anxiolytics, muscle relaxants, triptan, and/or anticonvulsants)
Patient SatisfactionUp to 3 hrsPatient satisfaction on a questionnaire at the end of the outpatient clinic visit, modeled after Press Ganey and averaged over 7 domains and groups. Assessment on Likert Scales from 1 (worst)-5 (best)
Average Maximal Pain During 1 Week After Treatment7 daysAverage of maximal daily pain as measured daily by self-report on a 0-10 scale with 0=no pain at all and 10=worst pain possible
Pain the End of the Waiting Room Time (Change as Compared to Beginning of the Waiting Room Time)Up to 60 minPain as measured by self-report on a 0-10 scale with 0=no pain at all and 10=worst pain possible; change from the beginning to the end of the waiting room time
Pain During Dental TreatmentUp to 120 minTime course of pain as measured by self-report on a 0-10 scale with 0=no pain at all and 10=worst pain possible (average over 10 minute intervals)

Countries

United States

Participant flow

Participants by arm

ArmCount
Comfort Talk® App Group
Patients will receive a tablet preloaded with the Comfort Talk® app in the dental waiting room on an intent-to-treat basis. They can listen as much or as little as they wish during waiting and during their dental treatment. Upon departure, they will receive a download coupon for the app for home use. Comfort Talk® app: Test app
37
White Noise Group
Patients will receive a tablet preloaded with a white noise app in the dental waiting room on an intent-to-treat basis. They can listen as much or as little as they wish during waiting and during their dental treatment. White Noise app: White Noise app built to mimic appearance of Comfort Talk® test app
35
Total72

Baseline characteristics

CharacteristicWhite Noise GroupTotalComfort Talk® App Group
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
8 Participants14 Participants6 Participants
Age, Categorical
Between 18 and 65 years
27 Participants58 Participants31 Participants
Anxiety2.5 units on a scale2.6 units on a scale2.6 units on a scale
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
34 Participants71 Participants37 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Pain2.8 units on a scale3.1 units on a scale3.4 units on a scale
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants7 Participants6 Participants
Race (NIH/OMB)
Black or African American
2 Participants2 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Race (NIH/OMB)
White
30 Participants61 Participants31 Participants
Region of Enrollment
United States
35 participants72 participants37 participants
Sex: Female, Male
Female
21 Participants50 Participants29 Participants
Sex: Female, Male
Male
14 Participants22 Participants8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 370 / 35
other
Total, other adverse events
0 / 370 / 35
serious
Total, serious adverse events
0 / 370 / 35

Outcome results

Primary

Number of Participants With Complete On-Site Data Sets

Feasibility defined as the ability to obtain complete on-site data sets from at least 90% of participants enrolled (with at least 40% from patients in the app group and at least 40% from patients in the control group).

Time frame: Duration of outpatient clinic visit (up to 2 hrs)

Population: Participants enrolled

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Comfort Talk® App GroupNumber of Participants With Complete On-Site Data Sets37 Participants
White Noise GroupNumber of Participants With Complete On-Site Data Sets35 Participants
Secondary

Number of Days to Enroll 60 Participants

Feasibility measure defined as the ability to enroll 60 participants by day 150 after initiation of recruitment in the clinic (=day 1). Outcome measure are numbers of office days from the start of enrollment

Time frame: Up to 150 days

Population: Number of participants within the cohort of the first 60 participants

ArmMeasureValue (NUMBER)
Comfort Talk® App GroupNumber of Days to Enroll 60 Participants106 Days
White Noise GroupNumber of Days to Enroll 60 Participants106 Days
Secondary

Number of Participants Returning Diary Card Packages

Follow-up feasibility defined as obtaining 38 packages of filled out diary cards (at least 16 from patients in the app group and at least 16 from patients in the control group)

Time frame: Up to 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Comfort Talk® App GroupNumber of Participants Returning Diary Card Packages15 Participants
White Noise GroupNumber of Participants Returning Diary Card Packages11 Participants
Other Pre-specified

Anxiety at the End of the Waiting Room Time (Change as Compared to Beginning of the Waiting Room Time)

Anxiety as measured by self-report on a 0-10 scale with 0=no anxiety at all and 10=worst anxiety possible; change from the beginning to the end of the waiting room time

Time frame: Up to 60 min

ArmMeasureValue (MEAN)
Comfort Talk® App GroupAnxiety at the End of the Waiting Room Time (Change as Compared to Beginning of the Waiting Room Time)-0.81 units on a scale
White Noise GroupAnxiety at the End of the Waiting Room Time (Change as Compared to Beginning of the Waiting Room Time)-0.66 units on a scale
p-value: <0.05Wilcoxon (Mann-Whitney)
Other Pre-specified

Anxiety During Dental Treatment

Time course of anxiety as measured by self-report on a 0-10 scale with 0=no anxiety at all and 10=worst anxiety possible (average over 10 minute intervals)

Time frame: Up to 120 min

ArmMeasureValue (MEAN)Dispersion
Comfort Talk® App GroupAnxiety During Dental Treatment2.2 units on a scaleStandard Deviation 2.1
White Noise GroupAnxiety During Dental Treatment2.0 units on a scaleStandard Deviation 1.7
Other Pre-specified

Average Maximal Anxiety During 1 Week After Dental Treatment

Average maximal daily anxiety as measured daily by self-report on a 0-10 scale with 0=no anxiety at all and 10=worst anxiety possible

Time frame: 7 days

Population: Participants who returned their diary card packages

ArmMeasureValue (MEAN)Dispersion
Comfort Talk® App GroupAverage Maximal Anxiety During 1 Week After Dental Treatment2.3 units on a scaleStandard Deviation 1.7
White Noise GroupAverage Maximal Anxiety During 1 Week After Dental Treatment2.3 units on a scaleStandard Deviation 1.9
Other Pre-specified

Average Maximal Pain During 1 Week After Treatment

Average of maximal daily pain as measured daily by self-report on a 0-10 scale with 0=no pain at all and 10=worst pain possible

Time frame: 7 days

Population: Participants who returned their diary card packages

ArmMeasureValue (MEAN)Dispersion
Comfort Talk® App GroupAverage Maximal Pain During 1 Week After Treatment2.9 units on a scaleStandard Deviation 1.4
White Noise GroupAverage Maximal Pain During 1 Week After Treatment3.1 units on a scaleStandard Deviation 1.2
Other Pre-specified

Number of Participants Receiving New Prescriptions for Drugs

Participants receiving new prescriptions for drugs at the end of their visit for the subsequent week (alone or in combination opioids, non-opioid analgesics, anxiolytics, muscle relaxants, triptan, and/or anticonvulsants)

Time frame: 7 days

Population: All enrolled participants

ArmMeasureValue (NUMBER)
Comfort Talk® App GroupNumber of Participants Receiving New Prescriptions for Drugs8 participants
White Noise GroupNumber of Participants Receiving New Prescriptions for Drugs5 participants
Other Pre-specified

Pain During Dental Treatment

Time course of pain as measured by self-report on a 0-10 scale with 0=no pain at all and 10=worst pain possible (average over 10 minute intervals)

Time frame: Up to 120 min

ArmMeasureValue (MEAN)Dispersion
Comfort Talk® App GroupPain During Dental Treatment2.5 units on a scaleStandard Deviation 2
White Noise GroupPain During Dental Treatment2.5 units on a scaleStandard Deviation 1.9
Other Pre-specified

Pain the End of the Waiting Room Time (Change as Compared to Beginning of the Waiting Room Time)

Pain as measured by self-report on a 0-10 scale with 0=no pain at all and 10=worst pain possible; change from the beginning to the end of the waiting room time

Time frame: Up to 60 min

ArmMeasureValue (MEAN)
Comfort Talk® App GroupPain the End of the Waiting Room Time (Change as Compared to Beginning of the Waiting Room Time)-0.76 units on a scale
White Noise GroupPain the End of the Waiting Room Time (Change as Compared to Beginning of the Waiting Room Time)-0.26 units on a scale
p-value: <0.05Wilcoxon (Mann-Whitney)
Other Pre-specified

Patient Satisfaction

Patient satisfaction on a questionnaire at the end of the outpatient clinic visit, modeled after Press Ganey and averaged over 7 domains and groups. Assessment on Likert Scales from 1 (worst)-5 (best)

Time frame: Up to 3 hrs

ArmMeasureValue (MEAN)
Comfort Talk® App GroupPatient Satisfaction4.6 units on a scale
White Noise GroupPatient Satisfaction4.6 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026